Can You Be a Surrogate with HPV?

Can you be a surrogate with HPV? In most cases, yes, HPV does not automatically disqualify you from becoming a surrogate. But there are guidelines.

Human papillomavirus (HPV) is the most common sexually transmitted infection in the U.S., affecting roughly 80% of sexually active adults at some point in their lives. Many women who have carried surrogate pregnancies have a history of HPV.

What matters is the current state of your cervical health — not the fact that HPV was ever detected. Whether your infection has cleared, what your most recent pap smear showed, and whether you’ve had any cervical procedures all factor into how our physician team evaluates your application.

Key Takeaways

A history of HPV does not automatically disqualify you from surrogacy — current cervical health is what matters.
Cleared HPV with normal, recent pap smear results is typically not a concern for surrogacy candidacy.
A history of LEEP or cone biopsy requires physician evaluation — the amount of cervical tissue removed and your subsequent pregnancy history both matter.
Active high-grade dysplasia (CIN 2 or CIN 3) typically requires treatment and clearance before moving forward.
At Physician’s Surrogacy, our OB/GYN team reviews your cervical history clinically — not a coordinator reviewing a form.

How HPV Is Evaluated for Surrogacy

Quick Answer

HPV itself doesn’t live in the uterus and has no effect on the embryo transfer process or the intended parents’ embryo. What physicians evaluate is the health of your cervix — specifically, whether HPV caused abnormal cell changes that required treatment, and whether your cervix has recovered well enough to safely support a surrogate pregnancy.

Most HPV infections clear on their own within two years. The immune system handles the virus without intervention, pap smears return to normal, and there’s no lasting impact on cervical health. For women in this situation, HPV history is rarely a concern in the surrogacy screening process.

The evaluation becomes more detailed when HPV caused cervical cell changes — known as cervical intraepithelial neoplasia (CIN) — that required a procedure like a LEEP or cone biopsy. In those cases, what matters is how much cervical tissue was removed and what your pregnancy history looks like since then.

Four Scenarios — and What Each Means for Eligibility

Not every HPV history looks the same. Here’s how our physician team approaches the four most common situations we see in applications:

Scenario 1: Cleared HPV, normal pap smears

Your infection resolved, your pap results are normal, and your cervical health is intact. This scenario is typically not a concern. Our physicians confirm the timeline and your most recent pap date, and the evaluation moves forward. This is the most common situation we see — and the clearest path to candidacy.

Scenario 2: History of LEEP or cone biopsy

LEEP and cone biopsy remove cervical tissue to treat abnormal cell changes. The clinical question is whether removing that tissue affects the cervix’s ability to support a full-term pregnancy. Our physicians review the size and depth of the procedure, your pap history since treatment, and critically — whether you’ve carried a successful pregnancy afterward. A post-LEEP pregnancy carried to term is strong evidence of cervical competency.

Scenario 3: Active low-grade dysplasia (CIN 1)

CIN 1 is a mild abnormality that often resolves on its own. Many physicians recommend watchful monitoring rather than immediate treatment. In surrogacy, this requires a discussion with our physician team — the timeline for resolution and your monitoring schedule factor into the evaluation. Active CIN 1 alone doesn’t automatically close the door.

Scenario 4: Active high-grade dysplasia (CIN 2 or CIN 3)

High-grade dysplasia requires treatment before surrogacy can move forward. This isn’t a permanent disqualification — it’s a timing issue. Once you’ve received treatment, cleared follow-up pap smears, and your cervical health is confirmed, the evaluation can proceed. Many women who had CIN 2 or CIN 3 in the past go on to become surrogates after clearance.

The LEEP Question: What the Research Actually Shows

LEEP is one of the most common procedures women ask about when applying to become surrogates. The concern is reasonable: removing cervical tissue could theoretically affect the cervix’s ability to stay closed during pregnancy — a condition called cervical insufficiency.

What Research Shows: LEEP and Pregnancy Outcomes

A matched cohort study published in Acta Obstetricia et Gynecologica Scandinavica found that LEEP did not significantly increase the risk of preterm birth or low birth weight in subsequent pregnancies — except when a large loop size (25mm or greater) was used. Standard, tissue-preserving LEEP showed no meaningful difference in pregnancy outcomes compared to women without the procedure.

In plain terms: most LEEP procedures — particularly conservative ones — don’t meaningfully change your ability to carry a pregnancy. The size and depth of the excision is what matters, not the procedure itself.

This is exactly why physician review makes the difference. A coordinator looking at “LEEP procedure: yes” on an application form has no way to distinguish a small, tissue-preserving excision from a large, aggressive one. Our OB/GYN team reviews the actual procedure notes and your obstetric history since.

If you carried a successful pregnancy after your LEEP — particularly a full-term delivery — that’s the strongest possible evidence that your cervix handled the procedure well. It’s a data point a physician weighs; a coordinator’s checklist can’t.

The Physician’s Advantage

Context Changes Everything. Checklists Miss It

Most agencies screen HPV and LEEP history with a binary yes/no. Our board-certified OB/GYNs read actual procedure notes, review pap timelines, and look at your post-LEEP pregnancy record. That’s the difference between a form rejection and an informed clinical decision.

Physician’s Surrogacy is the only U.S. surrogacy agency managed by practicing OB/GYNs — and our preterm delivery rate runs 50% below the national average.

Our physician-designed screening protocol goes beyond ASRM guidelines — and treats your history as a clinical picture, not a checkbox.

What About Genital Warts?

Genital warts are caused by low-risk HPV strains (types 6 and 11) — different strains from those that cause cervical dysplasia. They don’t cause cancer and don’t affect the uterus or the embryo transfer process.

A history of genital warts is not a disqualifier at Physician’s Surrogacy. Active genital warts present near delivery may prompt a C-section recommendation — the same precaution used for active genital herpes lesions — but this is a delivery management consideration, not an eligibility barrier.

What You’ll Need to Share During Screening

If you have a history of HPV, LEEP, or cervical dysplasia, the most useful information to have ready is:

  • Your most recent pap smear result and date — ideally within the past year
  • HPV high-risk strain test result (if available) — confirming whether the virus has cleared
  • LEEP or cone biopsy records — procedure date, size of excision if documented
  • Any pregnancies after the procedure — gestational age at delivery, any cervical insufficiency symptoms
  • Current monitoring schedule — whether you’re on a standard 3-year or more frequent surveillance plan

You don’t need to gather all of this before applying. The initial application takes about 10 minutes and simply confirms your state, age, and prior pregnancy history. Medical records come into play later in the screening process, once your basic eligibility is confirmed.

Before You Apply:
If you haven’t had a pap smear in the past two years, scheduling one before applying is worth doing. An up-to-date pap result is one of the first records our physician team will request, and having it ready speeds up the screening process considerably.

Surrogate Compensation at Physician’s Surrogacy

HPV history has no effect on surrogate compensation. Pay at Physician’s Surrogacy is determined by your state and experience — period.

First-time surrogates earn a flat-rate package starting at $60,000–$75,000+ based on state. The flat-rate package includes household allowance, childcare support, maternity clothing, and lost wages — no receipt tracking, no reimbursement system. Medical care, legal fees, and travel are covered separately by the intended parents.

A $1,250 pre-screening completion bonus applies once you clear the initial screening phase. See our full surrogate compensation breakdown for more detail on what’s included.

Apply in 10 Minutes

A Past HPV Diagnosis Doesn’t Define Your Candidacy

The initial application confirms your state and basic eligibility — it doesn’t ask for your full medical history. Apply first. Our physician team reviews the details that actually matter.

First-time surrogates start at $60,000–$75,000+ — experienced surrogates can earn more.

Our average match time is one week — vs. the industry standard of 6–12 months.

Become a Surrogate →

Other Conditions That Come Up During Screening

HPV is one of many conditions women wonder about when considering surrogacy. Our guide to surrogacy disqualifications covers the full range — from BMI and age to prior C-sections, herpes, and gestational diabetes — and explains how each is actually evaluated rather than reflexively declined. You can also review surrogate requirements, check BMI guidelines, or explore age eligibility if those are also on your mind.

The application is also the fastest way to know where you stand. It takes about 10 minutes, confirms your state immediately, and gets your profile to our physician team for a real review. A past HPV diagnosis — cleared, managed, or treated — has stopped too many women from even asking. Gestational surrogacy is one of the most medically sophisticated ways a family can be built — and one of the most human. Don’t let a checkbox make that decision for you.

While you’re here, you may also want to review the full surrogate requirements, explore why women choose to become surrogates, or read about the medical and emotional considerations involved. Our screening process overview also explains exactly what our physician team evaluates at each stage.

Frequently Asked Questions

Can HPV affect the embryo or intended parents’ genetic material? +
No. HPV is a cervical condition — it has no effect on the uterus, the embryo transfer process, or the intended parents’ embryo. The embryo is created externally at the fertility clinic and transferred directly into the uterus. HPV does not interfere with implantation or fetal development.
Do I need a current pap smear before applying? +
You don’t need one before submitting your application. The initial application is a quick eligibility check — state, age, prior pregnancy. A current pap smear will be requested during the medical screening phase, so having one within the past year ready is helpful but not required to start.
I had a LEEP and then delivered a baby at full term. Does that help my application? +
Yes — significantly. A full-term delivery after LEEP is strong clinical evidence that your cervix retained its integrity after the procedure. Our physician team weighs that history directly. It’s the kind of context that changes an uncertain evaluation into a clear one.
Will the intended parents be told about my HPV history? +
Full medical disclosure is required in gestational surrogacy. Relevant medical history — including HPV and any related procedures — is shared with intended parents as part of the matching process. This is standard practice across all agencies and is documented in your surrogacy contract.
What HPV strains are most relevant to surrogacy screening? +
High-risk strains (16, 18, 31, 33, and others) are those associated with cervical cell changes and cancer risk — these are what pap smears and HPV co-tests screen for. Low-risk strains (6 and 11) cause genital warts but not cervical dysplasia. Both are manageable in the surrogacy context; what matters is whether your cervix shows any active or unresolved changes.

!

Medical Disclaimer
The information in this article is for educational purposes only and does not constitute medical advice. Always consult your prescribing physician and your medical team regarding medication management and pregnancy safety.

Julianna Nikolic

Chief Strategy Officer Julianna Nikolic leads strategic initiatives, focusing on growth, innovation, and patient-centered solutions in the reproductive sciences sector. With 26+ years of management experience and a strong entrepreneurial background, she brings deep expertise to advancing reproductive healthcare.

LinkedIn

Begin your Journey with
Physician’s Surrogacy

Looking for Reliable Surrogacy Info?

Physician’s Surrogacy is the nation’s only physician-managed surrogacy agency. Join our community to get updates on surrogacy, expert insights, free resources and more.

By submitting this form, you agree to our Privacy Policy and Terms of Use and consent to receive occasional messages from Physician’s Surrogacy.

Looking for Reliable Surrogacy Info?

Physician’s Surrogacy is the nation’s only physician-managed surrogacy agency. Join our community to get updates on surrogacy, expert insights, free resources and more.

By submitting this form, you agree to our Privacy Policy and Terms of Use and consent to receive occasional messages from Physician’s Surrogacy.